(Q38122448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Developing new pharmacotherapies for autism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

C Ecker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

W Spooren

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

10 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

Journal of Internal Medicine

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

308-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23865950%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Advances in autism genetics: on the threshold of a new neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Autism spectrum disorders: developmental disconnection syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Functional impact of global rare copy number variation in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Cell adhesion molecules: signalling functions at the synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The trip of the tip: understanding the growth cone machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Control of excitatory and inhibitory synapse formation by neuroligins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Model of autism: increased ratio of excitation/inhibition in key neural systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Molecular dynamics of postsynaptic receptors and scaffold proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Autism: overestimation of the genetic origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Epigenetic factors and autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Genomic and epigenomic insights into nutrition and brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Is autism, at least in part, a disorder of fetal programming?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Early life programming and neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Activity-dependent neuronal signalling and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The International Collaboration for Autism Registry Epidemiology (iCARE): multinational registry-based investigations of autism risk factors and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Mining and modeling human genetics for autism therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Shank3 mutant mice display autistic-like behaviours and striatal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Dendritic spine pathology in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Neuroligins and neurexins link synaptic function to cognitive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Abnormal early brain development in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Cerebral lobes in autism: early hyperplasia and abnormal age effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Dynamic mapping of human cortical development during childhood through early adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Brain anatomy and its relationship to behavior in adults with autism spectrum disorder: a multicenter magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Large brains in autism: the challenge of pervasive abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Describing the brain in autism in five dimensions--magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Multi-voxel pattern analysis of fMRI data predicts clinical symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Atypical diffusion tensor hemispheric asymmetry in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

GABA system dysfunction in autism and related disorders: from synapse to symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Is there more to GABA than synaptic inhibition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The hyperglutamatergic hypothesis of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

A heterogeneity-based genome search meta-analysis for autism-spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Principles of diffusion tensor imaging and its applications to basic neuroscience research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Increased serum levels of glutamate in adult patients with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

The hyperserotonemia of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Hyperserotonemia in adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Association of tryptophan 2,3 dioxygenase gene polymorphism with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Autism and the serotonin transporter: the long and short of it

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Examination of association of genes in the serotonin system to autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Emerging Pharmacotherapies for Neurodevelopmental Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

EU-AIMS: a boost to autism research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113

Diagnosis in a dish: your skin can help your brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12113